
|Articles|August 1, 2003
Supplements and Featured Publications
- Examining the Dyslipidemia Constellation
- Volume 9
- Issue 1 Dyslipid
Atherosclerosis target of lipid-lowering therapy: Is Lower LDL cholesterol better?
Author(s)Peter H. Jones, MD
Advertisement
Articles in this issue
about 22 years ago
NCEP ATP III guidelines incorporate global risk assessmentabout 22 years ago
Case reports illustrate consequences of ATP III in practiceabout 22 years ago
Inflammatory markers are useful risk assessment toolsabout 22 years ago
IVUS is redefining atherosclerotic diseaseNewsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Reduction in Food Allergies Found After Guideline-Directed Early Peanut Exposure
2
FDA Expands Semaglutide Label to Reduce Cardiovascular Risk in Adults With Type 2 Diabetes
3
Adding Radioligand Therapy Pluvicto to SOC Cuts Risk of Prostate Cancer Progression or Death 28%, but How Many Doses?
4
Tezepelumab Becomes First TSLP-Targeting Biologic Approved by FDA for CRSwNP
5